Description

The global bariatric surgery market is poised to grow by US$ 875.1 million during 2022-2028, progressing at a CAGR of 6.4% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for bariatric surgery. The global bariatric surgery market is segmented on the basis of product, end user, and region. By product, the global bariatric surgery market has been segmented into assisting devices, implantable devices. In 2021, the assisting devices segment made up the largest share of revenue generated by the bariatric surgery market. Based upon end user, the global bariatric surgery market is categorized into ambulatory surgical centers (ASCs), bariatric surgery clinics, hospitals. The hospitals segment was the largest contributor to the global bariatric surgery market in 2021. Geographically, the global bariatric surgery market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). North America is estimated to account for the largest share of the global bariatric surgery market.

The assisting devices market is further segmented into stapling device, suturing device, and others. Among these, the stapling device segment was accounted for the highest revenue generator in 2021. Furthermore, the implantable devices market has been categorized into adjustable gastric-banding systems, intragastric balloon systems, and others. The intragastric balloon systems segment captured the largest share of the market in 2021 and is expected to maintain its dominance during the forecast period.

The global bariatric surgery market is highly competitive. The bariatric surgery market is dominated by key players, which are Apollo Endosurgery Inc., CONMED Corporation, Ethicon Inc. (Johnson & Johnson), Intuitive Surgical Inc., Medtronic plc, Obalon Therapeutics Inc., ReShape Lifesciences Inc. Competitive landscape gives a description of the competitive nature of the global bariatric surgery market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the bariatric surgery market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: assisting devices, implantable devices
End user: ambulatory surgical centers (ASCs), bariatric surgery clinics, hospitals
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Company mentioned: Apollo Endosurgery Inc., CONMED Corporation, Ethicon Inc. (Johnson & Johnson), Intuitive Surgical Inc., Medtronic plc, Obalon Therapeutics Inc., ReShape Lifesciences Inc.

Key Benefits for Stakeholders

– Get a comprehensive picture of the global bariatric surgery market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Bariatric surgery market overview
Part 3. Market breakdown by product
– Assisting devices
– Implantable devices
Part 4. Market breakdown by end user
– Ambulatory surgical centers (ASCs)
– Bariatric surgery clinics
– Hospitals
Part 5. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 6. Key companies
– Apollo Endosurgery, Inc.
– CONMED Corporation
– Ethicon, Inc. (Johnson & Johnson)
– Intuitive Surgical, Inc.
– Medtronic plc
– Obalon Therapeutics Inc.
– ReShape Lifesciences Inc.
About StrategyHelix
Disclaimer